Medical Care
Global mRNA Development and Manufacturing Services Market Research Report 2025
- Mar 11, 25
- ID: 108604
- Pages: 87
- Figures: 88
- Views: 16
The global market for mRNA Development and Manufacturing Services was valued at US$ 1254 million in the year 2024 and is projected to reach a revised size of US$ 2925 million by 2031, growing at a CAGR of 13.5% during the forecast period.
mRNA development and manufacturing services refer to the provision of full-process services from mRNA sequence design and optimization to large-scale production for pharmaceutical companies, biotechnology companies or research institutions. These services cover the research and development, preclinical research, clinical trial support and commercial production of mRNA drugs, aiming to accelerate the application of mRNA technology, especially in the fields of vaccines, therapeutic proteins and gene therapy.
North American market for mRNA Development and Manufacturing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for mRNA Development and Manufacturing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for mRNA Development and Manufacturing Services in Infectious disease and cancer vaccines is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of mRNA Development and Manufacturing Services include Thermo Fisher Scientific, AGC Biologics, WuXi Biologics, Samsung Biologics, Merck, ST Pharm, Aldevron, Curia, Lonza, Danaher Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for mRNA Development and Manufacturing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Development and Manufacturing Services.
The mRNA Development and Manufacturing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Development and Manufacturing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Development and Manufacturing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
AGC Biologics
WuXi Biologics
Samsung Biologics
Merck
ST Pharm
Aldevron
Curia
Lonza
Danaher Life Sciences
IDT
BioNTech
ProBio
Exothera
Segment by Type
mRNA Design and Synthesis
Delivery System Development
Other
Segment by Application
Infectious disease and cancer vaccines
Protein replacement therapy
Gene editing and cell therapy
Regenerative medicine therapy
Rare disease treatment
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Development and Manufacturing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
mRNA development and manufacturing services refer to the provision of full-process services from mRNA sequence design and optimization to large-scale production for pharmaceutical companies, biotechnology companies or research institutions. These services cover the research and development, preclinical research, clinical trial support and commercial production of mRNA drugs, aiming to accelerate the application of mRNA technology, especially in the fields of vaccines, therapeutic proteins and gene therapy.
North American market for mRNA Development and Manufacturing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for mRNA Development and Manufacturing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for mRNA Development and Manufacturing Services in Infectious disease and cancer vaccines is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of mRNA Development and Manufacturing Services include Thermo Fisher Scientific, AGC Biologics, WuXi Biologics, Samsung Biologics, Merck, ST Pharm, Aldevron, Curia, Lonza, Danaher Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for mRNA Development and Manufacturing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Development and Manufacturing Services.
The mRNA Development and Manufacturing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Development and Manufacturing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Development and Manufacturing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
AGC Biologics
WuXi Biologics
Samsung Biologics
Merck
ST Pharm
Aldevron
Curia
Lonza
Danaher Life Sciences
IDT
BioNTech
ProBio
Exothera
Segment by Type
mRNA Design and Synthesis
Delivery System Development
Other
Segment by Application
Infectious disease and cancer vaccines
Protein replacement therapy
Gene editing and cell therapy
Regenerative medicine therapy
Rare disease treatment
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Development and Manufacturing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Development and Manufacturing Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 mRNA Design and Synthesis
1.2.3 Delivery System Development
1.2.4 Other
1.3 Market by Application
1.3.1 Global mRNA Development and Manufacturing Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Infectious disease and cancer vaccines
1.3.3 Protein replacement therapy
1.3.4 Gene editing and cell therapy
1.3.5 Regenerative medicine therapy
1.3.6 Rare disease treatment
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Development and Manufacturing Services Market Perspective (2020-2031)
2.2 Global mRNA Development and Manufacturing Services Growth Trends by Region
2.2.1 Global mRNA Development and Manufacturing Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 mRNA Development and Manufacturing Services Historic Market Size by Region (2020-2025)
2.2.3 mRNA Development and Manufacturing Services Forecasted Market Size by Region (2026-2031)
2.3 mRNA Development and Manufacturing Services Market Dynamics
2.3.1 mRNA Development and Manufacturing Services Industry Trends
2.3.2 mRNA Development and Manufacturing Services Market Drivers
2.3.3 mRNA Development and Manufacturing Services Market Challenges
2.3.4 mRNA Development and Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Development and Manufacturing Services Players by Revenue
3.1.1 Global Top mRNA Development and Manufacturing Services Players by Revenue (2020-2025)
3.1.2 Global mRNA Development and Manufacturing Services Revenue Market Share by Players (2020-2025)
3.2 Global Top mRNA Development and Manufacturing Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by mRNA Development and Manufacturing Services Revenue
3.4 Global mRNA Development and Manufacturing Services Market Concentration Ratio
3.4.1 Global mRNA Development and Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Development and Manufacturing Services Revenue in 2024
3.5 Global Key Players of mRNA Development and Manufacturing Services Head office and Area Served
3.6 Global Key Players of mRNA Development and Manufacturing Services, Product and Application
3.7 Global Key Players of mRNA Development and Manufacturing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Development and Manufacturing Services Breakdown Data by Type
4.1 Global mRNA Development and Manufacturing Services Historic Market Size by Type (2020-2025)
4.2 Global mRNA Development and Manufacturing Services Forecasted Market Size by Type (2026-2031)
5 mRNA Development and Manufacturing Services Breakdown Data by Application
5.1 Global mRNA Development and Manufacturing Services Historic Market Size by Application (2020-2025)
5.2 Global mRNA Development and Manufacturing Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America mRNA Development and Manufacturing Services Market Size (2020-2031)
6.2 North America mRNA Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America mRNA Development and Manufacturing Services Market Size by Country (2020-2025)
6.4 North America mRNA Development and Manufacturing Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Development and Manufacturing Services Market Size (2020-2031)
7.2 Europe mRNA Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe mRNA Development and Manufacturing Services Market Size by Country (2020-2025)
7.4 Europe mRNA Development and Manufacturing Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Development and Manufacturing Services Market Size (2020-2031)
8.2 Asia-Pacific mRNA Development and Manufacturing Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific mRNA Development and Manufacturing Services Market Size by Region (2020-2025)
8.4 Asia-Pacific mRNA Development and Manufacturing Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Development and Manufacturing Services Market Size (2020-2031)
9.2 Latin America mRNA Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America mRNA Development and Manufacturing Services Market Size by Country (2020-2025)
9.4 Latin America mRNA Development and Manufacturing Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Development and Manufacturing Services Market Size (2020-2031)
10.2 Middle East & Africa mRNA Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa mRNA Development and Manufacturing Services Market Size by Country (2020-2025)
10.4 Middle East & Africa mRNA Development and Manufacturing Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific mRNA Development and Manufacturing Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 AGC Biologics
11.2.1 AGC Biologics Company Details
11.2.2 AGC Biologics Business Overview
11.2.3 AGC Biologics mRNA Development and Manufacturing Services Introduction
11.2.4 AGC Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.2.5 AGC Biologics Recent Development
11.3 WuXi Biologics
11.3.1 WuXi Biologics Company Details
11.3.2 WuXi Biologics Business Overview
11.3.3 WuXi Biologics mRNA Development and Manufacturing Services Introduction
11.3.4 WuXi Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.3.5 WuXi Biologics Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Details
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics mRNA Development and Manufacturing Services Introduction
11.4.4 Samsung Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.4.5 Samsung Biologics Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck mRNA Development and Manufacturing Services Introduction
11.5.4 Merck Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.5.5 Merck Recent Development
11.6 ST Pharm
11.6.1 ST Pharm Company Details
11.6.2 ST Pharm Business Overview
11.6.3 ST Pharm mRNA Development and Manufacturing Services Introduction
11.6.4 ST Pharm Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.6.5 ST Pharm Recent Development
11.7 Aldevron
11.7.1 Aldevron Company Details
11.7.2 Aldevron Business Overview
11.7.3 Aldevron mRNA Development and Manufacturing Services Introduction
11.7.4 Aldevron Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.7.5 Aldevron Recent Development
11.8 Curia
11.8.1 Curia Company Details
11.8.2 Curia Business Overview
11.8.3 Curia mRNA Development and Manufacturing Services Introduction
11.8.4 Curia Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.8.5 Curia Recent Development
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza mRNA Development and Manufacturing Services Introduction
11.9.4 Lonza Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.9.5 Lonza Recent Development
11.10 Danaher Life Sciences
11.10.1 Danaher Life Sciences Company Details
11.10.2 Danaher Life Sciences Business Overview
11.10.3 Danaher Life Sciences mRNA Development and Manufacturing Services Introduction
11.10.4 Danaher Life Sciences Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.10.5 Danaher Life Sciences Recent Development
11.11 IDT
11.11.1 IDT Company Details
11.11.2 IDT Business Overview
11.11.3 IDT mRNA Development and Manufacturing Services Introduction
11.11.4 IDT Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.11.5 IDT Recent Development
11.12 BioNTech
11.12.1 BioNTech Company Details
11.12.2 BioNTech Business Overview
11.12.3 BioNTech mRNA Development and Manufacturing Services Introduction
11.12.4 BioNTech Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.12.5 BioNTech Recent Development
11.13 ProBio
11.13.1 ProBio Company Details
11.13.2 ProBio Business Overview
11.13.3 ProBio mRNA Development and Manufacturing Services Introduction
11.13.4 ProBio Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.13.5 ProBio Recent Development
11.14 Exothera
11.14.1 Exothera Company Details
11.14.2 Exothera Business Overview
11.14.3 Exothera mRNA Development and Manufacturing Services Introduction
11.14.4 Exothera Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.14.5 Exothera Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Development and Manufacturing Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 mRNA Design and Synthesis
1.2.3 Delivery System Development
1.2.4 Other
1.3 Market by Application
1.3.1 Global mRNA Development and Manufacturing Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Infectious disease and cancer vaccines
1.3.3 Protein replacement therapy
1.3.4 Gene editing and cell therapy
1.3.5 Regenerative medicine therapy
1.3.6 Rare disease treatment
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Development and Manufacturing Services Market Perspective (2020-2031)
2.2 Global mRNA Development and Manufacturing Services Growth Trends by Region
2.2.1 Global mRNA Development and Manufacturing Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 mRNA Development and Manufacturing Services Historic Market Size by Region (2020-2025)
2.2.3 mRNA Development and Manufacturing Services Forecasted Market Size by Region (2026-2031)
2.3 mRNA Development and Manufacturing Services Market Dynamics
2.3.1 mRNA Development and Manufacturing Services Industry Trends
2.3.2 mRNA Development and Manufacturing Services Market Drivers
2.3.3 mRNA Development and Manufacturing Services Market Challenges
2.3.4 mRNA Development and Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Development and Manufacturing Services Players by Revenue
3.1.1 Global Top mRNA Development and Manufacturing Services Players by Revenue (2020-2025)
3.1.2 Global mRNA Development and Manufacturing Services Revenue Market Share by Players (2020-2025)
3.2 Global Top mRNA Development and Manufacturing Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by mRNA Development and Manufacturing Services Revenue
3.4 Global mRNA Development and Manufacturing Services Market Concentration Ratio
3.4.1 Global mRNA Development and Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Development and Manufacturing Services Revenue in 2024
3.5 Global Key Players of mRNA Development and Manufacturing Services Head office and Area Served
3.6 Global Key Players of mRNA Development and Manufacturing Services, Product and Application
3.7 Global Key Players of mRNA Development and Manufacturing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Development and Manufacturing Services Breakdown Data by Type
4.1 Global mRNA Development and Manufacturing Services Historic Market Size by Type (2020-2025)
4.2 Global mRNA Development and Manufacturing Services Forecasted Market Size by Type (2026-2031)
5 mRNA Development and Manufacturing Services Breakdown Data by Application
5.1 Global mRNA Development and Manufacturing Services Historic Market Size by Application (2020-2025)
5.2 Global mRNA Development and Manufacturing Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America mRNA Development and Manufacturing Services Market Size (2020-2031)
6.2 North America mRNA Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America mRNA Development and Manufacturing Services Market Size by Country (2020-2025)
6.4 North America mRNA Development and Manufacturing Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Development and Manufacturing Services Market Size (2020-2031)
7.2 Europe mRNA Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe mRNA Development and Manufacturing Services Market Size by Country (2020-2025)
7.4 Europe mRNA Development and Manufacturing Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Development and Manufacturing Services Market Size (2020-2031)
8.2 Asia-Pacific mRNA Development and Manufacturing Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific mRNA Development and Manufacturing Services Market Size by Region (2020-2025)
8.4 Asia-Pacific mRNA Development and Manufacturing Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Development and Manufacturing Services Market Size (2020-2031)
9.2 Latin America mRNA Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America mRNA Development and Manufacturing Services Market Size by Country (2020-2025)
9.4 Latin America mRNA Development and Manufacturing Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Development and Manufacturing Services Market Size (2020-2031)
10.2 Middle East & Africa mRNA Development and Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa mRNA Development and Manufacturing Services Market Size by Country (2020-2025)
10.4 Middle East & Africa mRNA Development and Manufacturing Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific mRNA Development and Manufacturing Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 AGC Biologics
11.2.1 AGC Biologics Company Details
11.2.2 AGC Biologics Business Overview
11.2.3 AGC Biologics mRNA Development and Manufacturing Services Introduction
11.2.4 AGC Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.2.5 AGC Biologics Recent Development
11.3 WuXi Biologics
11.3.1 WuXi Biologics Company Details
11.3.2 WuXi Biologics Business Overview
11.3.3 WuXi Biologics mRNA Development and Manufacturing Services Introduction
11.3.4 WuXi Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.3.5 WuXi Biologics Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Details
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics mRNA Development and Manufacturing Services Introduction
11.4.4 Samsung Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.4.5 Samsung Biologics Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck mRNA Development and Manufacturing Services Introduction
11.5.4 Merck Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.5.5 Merck Recent Development
11.6 ST Pharm
11.6.1 ST Pharm Company Details
11.6.2 ST Pharm Business Overview
11.6.3 ST Pharm mRNA Development and Manufacturing Services Introduction
11.6.4 ST Pharm Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.6.5 ST Pharm Recent Development
11.7 Aldevron
11.7.1 Aldevron Company Details
11.7.2 Aldevron Business Overview
11.7.3 Aldevron mRNA Development and Manufacturing Services Introduction
11.7.4 Aldevron Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.7.5 Aldevron Recent Development
11.8 Curia
11.8.1 Curia Company Details
11.8.2 Curia Business Overview
11.8.3 Curia mRNA Development and Manufacturing Services Introduction
11.8.4 Curia Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.8.5 Curia Recent Development
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza mRNA Development and Manufacturing Services Introduction
11.9.4 Lonza Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.9.5 Lonza Recent Development
11.10 Danaher Life Sciences
11.10.1 Danaher Life Sciences Company Details
11.10.2 Danaher Life Sciences Business Overview
11.10.3 Danaher Life Sciences mRNA Development and Manufacturing Services Introduction
11.10.4 Danaher Life Sciences Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.10.5 Danaher Life Sciences Recent Development
11.11 IDT
11.11.1 IDT Company Details
11.11.2 IDT Business Overview
11.11.3 IDT mRNA Development and Manufacturing Services Introduction
11.11.4 IDT Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.11.5 IDT Recent Development
11.12 BioNTech
11.12.1 BioNTech Company Details
11.12.2 BioNTech Business Overview
11.12.3 BioNTech mRNA Development and Manufacturing Services Introduction
11.12.4 BioNTech Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.12.5 BioNTech Recent Development
11.13 ProBio
11.13.1 ProBio Company Details
11.13.2 ProBio Business Overview
11.13.3 ProBio mRNA Development and Manufacturing Services Introduction
11.13.4 ProBio Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.13.5 ProBio Recent Development
11.14 Exothera
11.14.1 Exothera Company Details
11.14.2 Exothera Business Overview
11.14.3 Exothera mRNA Development and Manufacturing Services Introduction
11.14.4 Exothera Revenue in mRNA Development and Manufacturing Services Business (2020-2025)
11.14.5 Exothera Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global mRNA Development and Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of mRNA Design and Synthesis
Table 3. Key Players of Delivery System Development
Table 4. Key Players of Other
Table 5. Global mRNA Development and Manufacturing Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global mRNA Development and Manufacturing Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global mRNA Development and Manufacturing Services Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global mRNA Development and Manufacturing Services Market Share by Region (2020-2025)
Table 9. Global mRNA Development and Manufacturing Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global mRNA Development and Manufacturing Services Market Share by Region (2026-2031)
Table 11. mRNA Development and Manufacturing Services Market Trends
Table 12. mRNA Development and Manufacturing Services Market Drivers
Table 13. mRNA Development and Manufacturing Services Market Challenges
Table 14. mRNA Development and Manufacturing Services Market Restraints
Table 15. Global mRNA Development and Manufacturing Services Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global mRNA Development and Manufacturing Services Market Share by Players (2020-2025)
Table 17. Global Top mRNA Development and Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Development and Manufacturing Services as of 2024)
Table 18. Ranking of Global Top mRNA Development and Manufacturing Services Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by mRNA Development and Manufacturing Services Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of mRNA Development and Manufacturing Services, Headquarters and Area Served
Table 21. Global Key Players of mRNA Development and Manufacturing Services, Product and Application
Table 22. Global Key Players of mRNA Development and Manufacturing Services, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Development and Manufacturing Services Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global mRNA Development and Manufacturing Services Revenue Market Share by Type (2020-2025)
Table 26. Global mRNA Development and Manufacturing Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global mRNA Development and Manufacturing Services Revenue Market Share by Type (2026-2031)
Table 28. Global mRNA Development and Manufacturing Services Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global mRNA Development and Manufacturing Services Revenue Market Share by Application (2020-2025)
Table 30. Global mRNA Development and Manufacturing Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global mRNA Development and Manufacturing Services Revenue Market Share by Application (2026-2031)
Table 32. North America mRNA Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America mRNA Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America mRNA Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe mRNA Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe mRNA Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe mRNA Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific mRNA Development and Manufacturing Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific mRNA Development and Manufacturing Services Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific mRNA Development and Manufacturing Services Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America mRNA Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America mRNA Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America mRNA Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa mRNA Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa mRNA Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa mRNA Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific mRNA Development and Manufacturing Services Product
Table 50. Thermo Fisher Scientific Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. AGC Biologics Company Details
Table 53. AGC Biologics Business Overview
Table 54. AGC Biologics mRNA Development and Manufacturing Services Product
Table 55. AGC Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 56. AGC Biologics Recent Development
Table 57. WuXi Biologics Company Details
Table 58. WuXi Biologics Business Overview
Table 59. WuXi Biologics mRNA Development and Manufacturing Services Product
Table 60. WuXi Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 61. WuXi Biologics Recent Development
Table 62. Samsung Biologics Company Details
Table 63. Samsung Biologics Business Overview
Table 64. Samsung Biologics mRNA Development and Manufacturing Services Product
Table 65. Samsung Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 66. Samsung Biologics Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck mRNA Development and Manufacturing Services Product
Table 70. Merck Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 71. Merck Recent Development
Table 72. ST Pharm Company Details
Table 73. ST Pharm Business Overview
Table 74. ST Pharm mRNA Development and Manufacturing Services Product
Table 75. ST Pharm Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 76. ST Pharm Recent Development
Table 77. Aldevron Company Details
Table 78. Aldevron Business Overview
Table 79. Aldevron mRNA Development and Manufacturing Services Product
Table 80. Aldevron Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 81. Aldevron Recent Development
Table 82. Curia Company Details
Table 83. Curia Business Overview
Table 84. Curia mRNA Development and Manufacturing Services Product
Table 85. Curia Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 86. Curia Recent Development
Table 87. Lonza Company Details
Table 88. Lonza Business Overview
Table 89. Lonza mRNA Development and Manufacturing Services Product
Table 90. Lonza Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 91. Lonza Recent Development
Table 92. Danaher Life Sciences Company Details
Table 93. Danaher Life Sciences Business Overview
Table 94. Danaher Life Sciences mRNA Development and Manufacturing Services Product
Table 95. Danaher Life Sciences Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 96. Danaher Life Sciences Recent Development
Table 97. IDT Company Details
Table 98. IDT Business Overview
Table 99. IDT mRNA Development and Manufacturing Services Product
Table 100. IDT Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 101. IDT Recent Development
Table 102. BioNTech Company Details
Table 103. BioNTech Business Overview
Table 104. BioNTech mRNA Development and Manufacturing Services Product
Table 105. BioNTech Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 106. BioNTech Recent Development
Table 107. ProBio Company Details
Table 108. ProBio Business Overview
Table 109. ProBio mRNA Development and Manufacturing Services Product
Table 110. ProBio Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 111. ProBio Recent Development
Table 112. Exothera Company Details
Table 113. Exothera Business Overview
Table 114. Exothera mRNA Development and Manufacturing Services Product
Table 115. Exothera Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 116. Exothera Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. mRNA Development and Manufacturing Services Picture
Figure 2. Global mRNA Development and Manufacturing Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global mRNA Development and Manufacturing Services Market Share by Type: 2024 VS 2031
Figure 4. mRNA Design and Synthesis Features
Figure 5. Delivery System Development Features
Figure 6. Other Features
Figure 7. Global mRNA Development and Manufacturing Services Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global mRNA Development and Manufacturing Services Market Share by Application: 2024 VS 2031
Figure 9. Infectious disease and cancer vaccines Case Studies
Figure 10. Protein replacement therapy Case Studies
Figure 11. Gene editing and cell therapy Case Studies
Figure 12. Regenerative medicine therapy Case Studies
Figure 13. Rare disease treatment Case Studies
Figure 14. Other Case Studies
Figure 15. mRNA Development and Manufacturing Services Report Years Considered
Figure 16. Global mRNA Development and Manufacturing Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global mRNA Development and Manufacturing Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global mRNA Development and Manufacturing Services Market Share by Region: 2024 VS 2031
Figure 19. Global mRNA Development and Manufacturing Services Market Share by Players in 2024
Figure 20. Global mRNA Development and Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by mRNA Development and Manufacturing Services Revenue in 2024
Figure 22. North America mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America mRNA Development and Manufacturing Services Market Share by Country (2020-2031)
Figure 24. United States mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe mRNA Development and Manufacturing Services Market Share by Country (2020-2031)
Figure 28. Germany mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific mRNA Development and Manufacturing Services Market Share by Region (2020-2031)
Figure 36. China mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America mRNA Development and Manufacturing Services Market Share by Country (2020-2031)
Figure 44. Mexico mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa mRNA Development and Manufacturing Services Market Share by Country (2020-2031)
Figure 48. Turkey mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 52. AGC Biologics Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 53. WuXi Biologics Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 54. Samsung Biologics Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 56. ST Pharm Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 57. Aldevron Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 58. Curia Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 59. Lonza Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 60. Danaher Life Sciences Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 61. IDT Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 62. BioNTech Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 63. ProBio Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 64. Exothera Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global mRNA Development and Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of mRNA Design and Synthesis
Table 3. Key Players of Delivery System Development
Table 4. Key Players of Other
Table 5. Global mRNA Development and Manufacturing Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global mRNA Development and Manufacturing Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global mRNA Development and Manufacturing Services Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global mRNA Development and Manufacturing Services Market Share by Region (2020-2025)
Table 9. Global mRNA Development and Manufacturing Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global mRNA Development and Manufacturing Services Market Share by Region (2026-2031)
Table 11. mRNA Development and Manufacturing Services Market Trends
Table 12. mRNA Development and Manufacturing Services Market Drivers
Table 13. mRNA Development and Manufacturing Services Market Challenges
Table 14. mRNA Development and Manufacturing Services Market Restraints
Table 15. Global mRNA Development and Manufacturing Services Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global mRNA Development and Manufacturing Services Market Share by Players (2020-2025)
Table 17. Global Top mRNA Development and Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Development and Manufacturing Services as of 2024)
Table 18. Ranking of Global Top mRNA Development and Manufacturing Services Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by mRNA Development and Manufacturing Services Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of mRNA Development and Manufacturing Services, Headquarters and Area Served
Table 21. Global Key Players of mRNA Development and Manufacturing Services, Product and Application
Table 22. Global Key Players of mRNA Development and Manufacturing Services, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Development and Manufacturing Services Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global mRNA Development and Manufacturing Services Revenue Market Share by Type (2020-2025)
Table 26. Global mRNA Development and Manufacturing Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global mRNA Development and Manufacturing Services Revenue Market Share by Type (2026-2031)
Table 28. Global mRNA Development and Manufacturing Services Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global mRNA Development and Manufacturing Services Revenue Market Share by Application (2020-2025)
Table 30. Global mRNA Development and Manufacturing Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global mRNA Development and Manufacturing Services Revenue Market Share by Application (2026-2031)
Table 32. North America mRNA Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America mRNA Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America mRNA Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe mRNA Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe mRNA Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe mRNA Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific mRNA Development and Manufacturing Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific mRNA Development and Manufacturing Services Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific mRNA Development and Manufacturing Services Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America mRNA Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America mRNA Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America mRNA Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa mRNA Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa mRNA Development and Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa mRNA Development and Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific mRNA Development and Manufacturing Services Product
Table 50. Thermo Fisher Scientific Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. AGC Biologics Company Details
Table 53. AGC Biologics Business Overview
Table 54. AGC Biologics mRNA Development and Manufacturing Services Product
Table 55. AGC Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 56. AGC Biologics Recent Development
Table 57. WuXi Biologics Company Details
Table 58. WuXi Biologics Business Overview
Table 59. WuXi Biologics mRNA Development and Manufacturing Services Product
Table 60. WuXi Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 61. WuXi Biologics Recent Development
Table 62. Samsung Biologics Company Details
Table 63. Samsung Biologics Business Overview
Table 64. Samsung Biologics mRNA Development and Manufacturing Services Product
Table 65. Samsung Biologics Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 66. Samsung Biologics Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck mRNA Development and Manufacturing Services Product
Table 70. Merck Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 71. Merck Recent Development
Table 72. ST Pharm Company Details
Table 73. ST Pharm Business Overview
Table 74. ST Pharm mRNA Development and Manufacturing Services Product
Table 75. ST Pharm Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 76. ST Pharm Recent Development
Table 77. Aldevron Company Details
Table 78. Aldevron Business Overview
Table 79. Aldevron mRNA Development and Manufacturing Services Product
Table 80. Aldevron Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 81. Aldevron Recent Development
Table 82. Curia Company Details
Table 83. Curia Business Overview
Table 84. Curia mRNA Development and Manufacturing Services Product
Table 85. Curia Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 86. Curia Recent Development
Table 87. Lonza Company Details
Table 88. Lonza Business Overview
Table 89. Lonza mRNA Development and Manufacturing Services Product
Table 90. Lonza Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 91. Lonza Recent Development
Table 92. Danaher Life Sciences Company Details
Table 93. Danaher Life Sciences Business Overview
Table 94. Danaher Life Sciences mRNA Development and Manufacturing Services Product
Table 95. Danaher Life Sciences Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 96. Danaher Life Sciences Recent Development
Table 97. IDT Company Details
Table 98. IDT Business Overview
Table 99. IDT mRNA Development and Manufacturing Services Product
Table 100. IDT Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 101. IDT Recent Development
Table 102. BioNTech Company Details
Table 103. BioNTech Business Overview
Table 104. BioNTech mRNA Development and Manufacturing Services Product
Table 105. BioNTech Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 106. BioNTech Recent Development
Table 107. ProBio Company Details
Table 108. ProBio Business Overview
Table 109. ProBio mRNA Development and Manufacturing Services Product
Table 110. ProBio Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 111. ProBio Recent Development
Table 112. Exothera Company Details
Table 113. Exothera Business Overview
Table 114. Exothera mRNA Development and Manufacturing Services Product
Table 115. Exothera Revenue in mRNA Development and Manufacturing Services Business (2020-2025) & (US$ Million)
Table 116. Exothera Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. mRNA Development and Manufacturing Services Picture
Figure 2. Global mRNA Development and Manufacturing Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global mRNA Development and Manufacturing Services Market Share by Type: 2024 VS 2031
Figure 4. mRNA Design and Synthesis Features
Figure 5. Delivery System Development Features
Figure 6. Other Features
Figure 7. Global mRNA Development and Manufacturing Services Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global mRNA Development and Manufacturing Services Market Share by Application: 2024 VS 2031
Figure 9. Infectious disease and cancer vaccines Case Studies
Figure 10. Protein replacement therapy Case Studies
Figure 11. Gene editing and cell therapy Case Studies
Figure 12. Regenerative medicine therapy Case Studies
Figure 13. Rare disease treatment Case Studies
Figure 14. Other Case Studies
Figure 15. mRNA Development and Manufacturing Services Report Years Considered
Figure 16. Global mRNA Development and Manufacturing Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global mRNA Development and Manufacturing Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global mRNA Development and Manufacturing Services Market Share by Region: 2024 VS 2031
Figure 19. Global mRNA Development and Manufacturing Services Market Share by Players in 2024
Figure 20. Global mRNA Development and Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by mRNA Development and Manufacturing Services Revenue in 2024
Figure 22. North America mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America mRNA Development and Manufacturing Services Market Share by Country (2020-2031)
Figure 24. United States mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe mRNA Development and Manufacturing Services Market Share by Country (2020-2031)
Figure 28. Germany mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific mRNA Development and Manufacturing Services Market Share by Region (2020-2031)
Figure 36. China mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America mRNA Development and Manufacturing Services Market Share by Country (2020-2031)
Figure 44. Mexico mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa mRNA Development and Manufacturing Services Market Share by Country (2020-2031)
Figure 48. Turkey mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE mRNA Development and Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 52. AGC Biologics Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 53. WuXi Biologics Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 54. Samsung Biologics Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 56. ST Pharm Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 57. Aldevron Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 58. Curia Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 59. Lonza Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 60. Danaher Life Sciences Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 61. IDT Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 62. BioNTech Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 63. ProBio Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 64. Exothera Revenue Growth Rate in mRNA Development and Manufacturing Services Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232